.png)
The Shift from Animal to iPSC-Derived Models in Preclinical Research
-1.png)
The status of drug discovery and development for Parkinson's disease

ALS Pathology and Drug Targets Using In Vitro iPSC Models
-1.png)
The status of drug discovery and development for Alzheimer's disease

Case Study: Modeling Friedreich’s ataxia using patient-derived iPSCs

White paper: Advancing drug discovery for neurodegenerative diseases
